3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Uterine cancer may raise ovarian cancer risk

CancerOct 08, 05

As many as one quarter of young women with uterine cancer also have ovarian cancer, new research suggests.

Several groups advocate ovary-sparing treatment to safeguard fertility in young women with uterine cancer, the authors explain, but reports have suggested that these women have ovarian cancer rates ranging from 5 to 29 percent, according to a report in the journal Obstetrics & Gynecology.

Dr. Ilana Cass from UCLA and Cedars-Sinai Medical Center, Los Angeles, and colleagues investigated the frequency of coexisting ovarian cancer in 102 women, age 45 years or younger, who underwent hysterectomy for uterine cancer.

Twenty-six of the women, or 25 percent, had coexisting ovarian cancer, the authors report. Aside from three cases in which the ovarian cancer had spread from uterine cancer, all of the ovarian cancers were new, separate cancers.

Most of the cases occurred in women with early uterine cancer. Moreover, in a few cases, standard X-ray methods failed to detect the ovarian cancer.

“Based on our data, we would recommend a cautious approach to (ovary-sparing treatment) in young patients with uterine cancer,” the authors conclude. “The high incidence of coexisting (cancer) in the ovaries and the young age of diagnosis suggest an increased susceptibility of the reproductive organs to” becoming cancerous.

“If the ovaries are preserved at the time of hysterectomy,” the researchers advise, “patients may need continued postoperative surveillance” of the fallopian tubes and ovaries. At the minimum, careful assessment of the fallopian tubes and ovaries is warranted in all young patients with uterine cancer.

SOURCE: Obstetrics and Gynecology, October 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site